Glenmark Pharmaceuticals informs about board meeting
Glenmark Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 to consider and approve the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2025.
The above information is a part of company’s filings submitted to BSE.
